Skip to main content
. 2022 Aug 31;9:978407. doi: 10.3389/fsurg.2022.978407

Table 4.

GRADE assessment for outcomes reported in RCTs on collagen vs. standard of care for chronic wounds.

Outcomes No. of studies Study design Risk of bias Inconsistency Indirectness Imprecision Other considerations No. of patients
Relative effect (95% CI) Certaintya
Collagen SOC
Wound healing rate 11 RCT Seriousb No No No No 484 473 RR = 1.53 (1.33, 1.77) ⊕⊕⊕○ Moderate
Healing velocity 2 RCT No No No No No 171 166 MD = 2.69 (0.87, 4.51) ⊕⊕⊕⊕ High
Recurrence of ulceration 3 RCT No Seriousc No No No 114 53 RR = 0.47 (0.27, 0.79) ⊕⊕⊕○ Moderate
Adverse events 7 RCT No No No No No 281 274 RR = 0.67 (0.44, 1.01) ⊕⊕⊕⊕ High

RCT, randomized controlled trial; MD, mean difference; CI, confidence interval; RR, risk ratio; SOC, standard of care.

a

GRADE Working Group grades of evidence: High quality = we are very confident that the true effect lies close to that of the estimate of the effect.; Moderate quality = we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different; Low quality = our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect; Very low quality = we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

b

Downgraded one level for concerns with performance bias.

c

Downgraded one level for I2 > 50%.